FF
JAZZ icon

Friedenthal Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Friedenthal Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
+4,610
New +$1.01M 0.51% 52
2025
Q2 		– Sell
-6,915
Closed -$858K – 289
2025
Q1 		$858K Buy
+6,915
New +$902K 0.51% 72

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Friedenthal Financial's JAZZ Position: Q2 2026 in Review

Friedenthal Financial opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 4,610 shares worth $1.11M. The stake represents 0.51% of the portfolio and ranks #52 among its holdings. This is a return to the name: Friedenthal Financial previously reported a position in JAZZ as recently as Q1 2025.

Friedenthal Financial first reported a position in JAZZ in Q1 2025 and has held it in 2 quarters since. 98 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Friedenthal Financial held 4,610 shares of Jazz Pharmaceuticals worth $1.11M as of Q2 2026.
  • Jazz Pharmaceuticals was a new Friedenthal Financial position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.51% of Friedenthal Financial's portfolio in Q2 2026, its #52 holding.
  • Friedenthal Financial first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • 98 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Friedenthal Financial's 13F filing for Q2 2026, filed 13 Jul 2026.